Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management
Authors
Keywords
-
Journal
Cancers
Volume 15, Issue 4, Pages 1077
Publisher
MDPI AG
Online
2023-02-08
DOI
10.3390/cancers15041077
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Socioeconomic Status and Race/Ethnicity in Malignant Peripheral Nerve Sheath Tumor Survival: A Surveillance, Epidemiology and End Results Based Analysis
- (2022) Allison M. Domingues et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prevalence and detection of actionable BRAF V600 and NRAS Q61 mutations in malignant peripheral nerve sheath tumor by droplet digital PCR
- (2022) Erica Y. Kao et al. HUMAN PATHOLOGY
- Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
- (2021) Sumanth Nagabushan et al. npj Precision Oncology
- Diagnostic Accuracy of MRI for the Detection of Malignant Peripheral Nerve Sheath Tumors: A Systematic Review and Meta-Analysis
- (2021) Mitchell P. Wilson et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions
- (2021) Hildegard Kehrer-Sawatzki et al. HUMAN GENETICS
- Toward Understanding the Mechanisms of Malignant Peripheral Nerve Sheath Tumor Development
- (2021) Teddy Mohamad et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Fédération Nationale Des Centres de Lutte Contre Le Cancer (FNCLCC) Grading, Margin Status and Tumor Location Associate With Survival Outcomes in Malignant Peripheral Nerve Sheath Tumors
- (2021) Kristina M. Wakeman et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Prognosis and risk factors for malignant peripheral nerve sheath tumor: a systematic review and meta-analysis
- (2020) Zhenyu Cai et al. World Journal of Surgical Oncology
- Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define pre-malignant neurofibromatosis type 1-associated atypical neurofibromas
- (2019) Alexander Pemov et al. NEURO-ONCOLOGY
- Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation
- (2019) Steven D Rhodes et al. HUMAN MOLECULAR GENETICS
- Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study
- (2019) Penghui Yan et al. JOURNAL OF NEURO-ONCOLOGY
- Trametinib Induces Neurofibroma Shrinkage and Enables Surgery
- (2019) Pia Vaassen et al. NEUROPEDIATRICS
- Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST
- (2019) Ruoyu Miao et al. RADIOTHERAPY AND ONCOLOGY
- Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center
- (2019) Danielle S. Graham et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Malignant peripheral nerve sheath tumors: Analysis of the national cancer database
- (2019) Alia Mowery et al. ORAL ONCOLOGY
- A nationwide cohort study on treatment and survival in patients with malignant peripheral nerve sheath tumours
- (2019) Enrico Martin et al. EUROPEAN JOURNAL OF CANCER
- Genomic status of MET potentiates sensitivity to MET and MEK inhibition in NF1-related malignant peripheral nerve sheath tumors
- (2018) Jacqueline D Peacock et al. CANCER RESEARCH
- Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: Correlating histological and genomic findings
- (2018) Meritxell Carrió et al. HUMAN MUTATION
- SPRINT: Phase II study of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).
- (2018) Andrea M. Gross et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Profiling in Patients With Malignant Peripheral Nerve Sheath Tumors Reveals Multiple Pathways With Targetable Mutations
- (2018) Henry G. Kaplan et al. Journal of the National Comprehensive Cancer Network
- Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI
- (2018) Christian Philipp Reinert et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Polycomb repression regulates Schwann cell proliferation and axon regeneration after nerve injury
- (2018) Ki H. Ma et al. GLIA
- Long-Term Outcomes of Radiation Therapy (RT) in the Management of Malignant Peripheral Nerve Sheath Tumors (MPNST) in Patients with Neurofibromatosis Type 1 (NF1)
- (2018) L. Sloan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- mTOR as a central hub of nutrient signalling and cell growth
- (2018) Joungmok Kim et al. NATURE CELL BIOLOGY
- NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation
- (2018) Jean-Philippe Brosseau et al. Nature Communications
- Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a consensus overview
- (2017) Markku M. Miettinen et al. HUMAN PATHOLOGY
- Radiation-Induced Malignant Peripheral Nerve Sheath Tumors: A Systematic Review
- (2017) Ryuya Yamanaka et al. World Neurosurgery
- Neurofibromatosis type 1
- (2017) David H. Gutmann et al. Nature Reviews Disease Primers
- Results of a Sarcoma Alliance for Research through Collaboration (SARC) phase II trial of dasatinib in previously treated, high-grade, advanced sarcoma.
- (2017) S. Schuetze et al. JOURNAL OF CLINICAL ONCOLOGY
- Vemurafenib Treatment ofBRAFV600E-Mutated Malignant Peripheral Nerve Sheath Tumor
- (2017) Henry G. Kaplan Journal of the National Comprehensive Cancer Network
- Methylation-based classification of benign and malignant peripheral nerve sheath tumors
- (2016) Manuel Röhrich et al. ACTA NEUROPATHOLOGICA
- Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis
- (2016) Sophie Le Guellec et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST
- (2016) Carlos N. Prieto-Granada et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
- (2016) T. Valentin et al. EUROPEAN JOURNAL OF CANCER
- Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival
- (2016) Arjen H G Cleven et al. MODERN PATHOLOGY
- 173 A Clinical and Radiographic Score to Assess Malignant Potential of Peripheral Nerve Sheath Tumors
- (2016) Jonathan Yun et al. NEUROSURGERY
- Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
- (2016) Eva Dombi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Evaluation of 18F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors
- (2016) Stephen M. Broski et al. SKELETAL RADIOLOGY
- Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation
- (2016) Angela C. Hirbe et al. Oncotarget
- Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial
- (2015) Dian Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and Mortality of Neurofibromatosis: A Total Population Study in Finland
- (2015) Elina Uusitalo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany
- (2015) D. L. Bailey et al. MOLECULAR IMAGING AND BIOLOGY
- Malignant peripheral nerve sheath tumour arising de novo from ganglioneuroma
- (2015) T.C. Mow et al. PATHOLOGY
- Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients
- (2015) Mehdi Brahmi et al. PLoS One
- Accuracy and complications of CT-guided core needle biopsy of peripheral nerve sheath tumours
- (2015) Marcus Pianta et al. SKELETAL RADIOLOGY
- Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas
- (2014) Melike Pekmezci et al. MODERN PATHOLOGY
- PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
- (2014) William Lee et al. NATURE GENETICS
- Malignant Peripheral Nerve Sheath Tumors
- (2014) M. Farid et al. ONCOLOGIST
- Radiation Therapy in Management of Sporadic and Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors
- (2014) Jenna Kahn et al. Frontiers in Oncology
- Malignant peripheral nerve sheath tumor: pathology and genetics
- (2013) Khin Thway et al. Annals of Diagnostic Pathology
- The Activation of the WNT Signaling Pathway Is a Hallmark in Neurofibromatosis Type 1 Tumorigenesis
- (2013) A. Luscan et al. CLINICAL CANCER RESEARCH
- EGFR–STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors
- (2013) J Wu et al. ONCOGENE
- Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review
- (2013) Ouidad Zehou et al. Orphanet Journal of Rare Diseases
- Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition
- (2012) Carlos E. Prada et al. ACTA NEUROPATHOLOGICA
- Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors
- (2012) M. Endo et al. CLINICAL CANCER RESEARCH
- MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
- (2012) Walter J. Jessen et al. JOURNAL OF CLINICAL INVESTIGATION
- [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation
- (2012) L. L. Tsai et al. JOURNAL OF NEURO-ONCOLOGY
- Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis Type 1
- (2012) Gavin P. Dunn et al. JOURNAL OF NEUROSURGERY
- Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial
- (2012) Kent A Robertson et al. LANCET ONCOLOGY
- Vemurafenib: the first drug approved for BRAF-mutant cancer
- (2012) Gideon Bollag et al. NATURE REVIEWS DRUG DISCOVERY
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1
- (2012) M. Kolberg et al. NEURO-ONCOLOGY
- Sox10 and S100 in the Diagnosis of Soft-tissue Neoplasms
- (2012) Jason R. Karamchandani et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Malignant Peripheral Nerve Sheath Tumors (MPNST): The Mayo Clinic Experience
- (2011) Chee-Chee H. Stucky et al. ANNALS OF SURGICAL ONCOLOGY
- Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system
- (2011) Nicole M. Brossier et al. BRAIN RESEARCH BULLETIN
- Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
- (2011) Thomas De Raedt et al. CANCER CELL
- Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989
- (2011) D Gareth R Evans et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Frequency and Associated Clinical Deficits
- (2011) Rosa Nguyen et al. JOURNAL OF PEDIATRICS
- Post-radiation sarcomas. Clinical outcome of 52 Patients
- (2011) Andreas F. Mavrogenis et al. JOURNAL OF SURGICAL ONCOLOGY
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study
- (2010) J. R. Kroep et al. ANNALS OF ONCOLOGY
- Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome
- (2009) Changye Zou et al. ANNALS OF SURGERY
- Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign
- (2009) Matthias R. Benz et al. CANCER
- Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways
- (2009) Daniela Katz et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model
- (2009) Rashmi Chugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
- (2009) Robert G. Maki et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53Mutation Analysis of Malignant Peripheral Nerve Sheath Tumors
- (2009) Robert M. Verdijk et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Plexiform and Dermal Neurofibromas and Pigmentation Are Caused by Nf1 Loss in Desert Hedgehog-Expressing Cells
- (2008) Jianqiang Wu et al. CANCER CELL
- Nf1-Dependent Tumors Require a Microenvironment Containing Nf1+/−- and c-kit-Dependent Bone Marrow
- (2008) Feng-Chun Yang et al. CELL
- Germline and somaticNF1gene mutations in plexiform neurofibromas
- (2008) Meena Upadhyaya et al. HUMAN MUTATION
- Germline and somaticNF1mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours
- (2008) Irene Bottillo et al. JOURNAL OF PATHOLOGY
- Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells
- (2008) G. Ambrosini et al. MOLECULAR CANCER THERAPEUTICS
- Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors
- (2008) G. Johansson et al. MOLECULAR CANCER THERAPEUTICS
- Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1
- (2008) Victor-F. Mautner et al. NEURO-ONCOLOGY
- EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy
- (2008) Nikola Holtkamp et al. NEURO-ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now